Related Experiment Video
Updated: Mar 30, 2026
09:02
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.5K
Splenic abscess in cancer chemotherapy
Essadi Ismail1, Rachid El Barni2, Mohamed Lahkim3
1Medical Oncology Unit, IBN SINA Military Hospital, Marrakesh, Morocco. ismail_onco@yahoo.fr.
BMC Research Notes
|November 13, 2015
Summary
Splenic abscess is a rare but serious complication of cancer treatment, particularly in immunocompromised patients. Early detection and tailored treatment are crucial for improving outcomes in these high-mortality cases.
Area of Science:
- Oncology
- Infectious Diseases
Background:
- Splenic abscess is an uncommon but severe complication following cancer treatment.
- It disproportionately affects immunocompromised individuals, leading to high mortality rates.
- Classic diagnostic signs are infrequent, with varied clinical presentations from asymptomatic to severe systemic symptoms.
Observation:
- A 62-year-old male with metastatic lung adenocarcinoma developed a splenic abscess after chemotherapy.
- The patient presented with symptoms indicative of this rare complication.
Findings:
- The case highlights the diagnostic challenges of splenic abscess.
- It underscores the need for vigilance in cancer patients undergoing treatment.
Implications:
- Active surveillance for splenic abscess is essential in immunocompromised cancer patients.
- Personalized therapeutic strategies are necessary for optimal patient management and improved survival rates.
